On March 1, the U.S. Food and Drug Administration (FDA) approved Odactra, the first allergen extract to be administered sublingually to treat house dust mite (HDM)-induced allergic rhinitis,…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.